Maureen O'Brien Moomjy, M.D.
Opted out of Medicare from January 2014 to January 2028. Obstetrics & Gynecology, Reproductive Endocrinology (M.D.) in New York, New York, licensed in NY, with an NPI issued in November 2006. Part D covered 59 prescriptions written in 2024, 92% of them generic. Millicent US Inc was the largest of 6 companies reporting payments in 2025, $463.31 in all, mostly food and beverage.
Overview
| NPI | 1043399454 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Nov 4, 2006 |
| Last updated in NPPES | Mar 5, 2019 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Obstetrics & Gynecology, Reproductive Endocrinology Primary | 207VE0102X | 189878 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Jan 1, 2014 – Jan 1, 2028 |
| Can order and refer | Yes |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 59 · 91 30-day fills |
|---|---|
| Patients | 18 |
| Total drug cost | $3,310 |
| Generic share | 92% of claims |
Industry payments (Open Payments)
- 2025$463.31 · 17 payments from 6 companies
- 2024$279.19 · 15 payments from 8 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Millicent US Inc | $178.84 | 5 |
| Mayne Pharma Commercial LLC | $108.99 | 4 |
| Astellas Pharma US Inc | $66.65 | 3 |
| Novo Nordisk Inc | $47.99 | 2 |
| Ferring Pharmaceuticals Inc. | $33.32 | 2 |
What the 2025 payments were for
- Food and Beverage$373.31 · 16 payments
- Education$90.00 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Obstetrics & Gynecology, Reproductive Endocrinology providers in New York
- 1962677195
- 1821249715
- 1477299782
- 1912445859
- 1184128340
- 1811880222
- 1992650758
- 1144554601
- 1548038342
- 1124627799
- 1598317091
- 1518439579
All Obstetrics & Gynecology, Reproductive Endocrinology providers in New York →